Quadcap Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.65M Sell
1,790
-153
-8% -$155K 0.19% 104
2025
Q4
$2.07M Buy
1,943
+236
+14% +$226K 0.24% 88
2025
Q3
$1.3M Sell
1,707
-1,041
-38% -$775K 0.15% 125
2025
Q2
$2.14M Buy
2,748
+268
+11% +$208K 0.27% 72
2025
Q1
$2.05M Sell
2,480
-55
-2% -$45.8K 0.3% 71
2024
Q4
$1.96M Sell
2,535
-491
-16% -$407K 0.29% 72
2024
Q3
$2.68M Buy
3,026
+376
+14% +$338K 0.42% 51
2024
Q2
$2.4M Buy
2,650
+838
+46% +$670K 0.43% 46
2024
Q1
$1.41M Buy
1,812
+432
+31% +$307K 0.32% 69
2023
Q4
$804K Buy
+1,380
New +$806K 0.21% 133

Other funds holding LLY

Quadcap Wealth Management's LLY Position: Q1 2026 in Review

Quadcap Wealth Management reduced its Eli Lilly (LLY) stake by 7.9% in Q1 2026, selling an estimated $155K and leaving 1,790 shares worth $1.65M. The position accounts for 0.19% of the portfolio, ranked #104.

Quadcap Wealth Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.68M in Q3 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Quadcap Wealth Management held 1,790 shares of Eli Lilly worth $1.65M as of Q1 2026.
  • Quadcap Wealth Management sold 153 Eli Lilly shares in Q1 2026, an estimated $155K.
  • Eli Lilly made up 0.19% of Quadcap Wealth Management's portfolio in Q1 2026, its #104 holding.
  • Quadcap Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Quadcap Wealth Management's Eli Lilly position peaked at $2.68M in Q3 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Quadcap Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.